The UC Davis MIND Institute IDDRC Rodent Behavior Core (RBC) is fundamental to Center projects seeking to understand the biological mechanisms underlying IDD and to pursue translational discovery of therapeutics. This is a completely new core that builds on existing and newly available resources and expertise at the MIND Institute and UC Davis. Its goal is to meet the high demand for behavioral testing of rodent models of IDD at UC Davis. The RBC will assist investigators with IDDRC projects in generating high-quality behavioral data for publication, preclinical discoveries to inform human clinical trials, and pilot data for new studies. Further, the availability of the services of the RBC is likely to encourage additional UC Davis researchers to become interested in entering the IDD research field and becoming members of the IDDRC, and we will support this interest through active outreach efforts. Comprehensive behavioral assays relevant to IDD, including those developed by Drs. Crawley and Berman, are employed worldwide to understand causal mechanisms and develop effective therapeutics. The proposed RBC will employ standardized and innovative behavioral assays relevant to the behavioral symptoms of IDD. Services will include (a) access to modern, efficient, start-of-the-art behavioral testing facilities; (b) training for investigators and their staff in behavioral assay procedures and the use of behavioral testing equipment; (c) hands-on supervision in all aspects of behavioral testing and equipment use; (d) consultation on experimental design and interpretation of results; (e) assistance in developing new assays required by users; (f) training and supervision in drug administration for behavioral pharmacology studies; (g) access to facilities for harvesting tissue from behaviorally tested mice and rats; (h) access to mutant mouse and rat models; (i) guidance to access related resources at UC Davis, including core facilities for genetics and for generating new lines of mutant mice; and (j) facilitation of collaborations between IDDRC investigators. Services will further include (k) consultation for preparing lACUC protocols, grant applications, and manuscripts. In addition, the core will offer (I) direct behavioral testing services conducted by core staff. Expertise of the core director, co-director, and managers includes extensive knowledge and experience in animal models of IDD conditions, behavioral phenotyping of mice with targeted gene mutations, behavioral phenotyping of inbred strains of mice and rats, and behavioral responses to drug treatments, immune challenges, and environmental toxins in mice and rats. Mouse facilities are located at the UC Davis School of Medicine campus in Sacramento. Rat facilities are located at the nearby main campus in Davis. A high level of scientific and practical interactions is already in place between the two sites. Five tiers of service usage will be offered: (1) consultation; (2) unsupervised use of equipment available in the core facilities; (3) training and supervision in conducting behavioral tests using core equipment; (4) battery of assays conducted by core staff; and (5) tailored sets of assays conducted by core staff. Combinations of services will be designed to match the needs of each user.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
4U54HD079125-04
Application #
9110746
Study Section
Special Emphasis Panel (ZHD1)
Project Start
Project End
Budget Start
2016-06-01
Budget End
2017-05-31
Support Year
4
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Kerin, Tara; Volk, Heather; Li, Weiyan et al. (2018) Association Between Air Pollution Exposure, Cognitive and Adaptive Function, and ASD Severity Among Children with Autism Spectrum Disorder. J Autism Dev Disord 48:137-150
Ozonoff, Sally; Li, Deana; Deprey, Lesley et al. (2018) Reliability of parent recall of symptom onset and timing in autism spectrum disorder. Autism 22:891-896
Benyakorn, Songpoom; Calub, Catrina A; Riley, Steven J et al. (2018) Computerized Cognitive Training in Children With Autism and Intellectual Disabilities: Feasibility and Satisfaction Study. JMIR Ment Health 5:e40
Weir, R K; Bauman, M D; Jacobs, B et al. (2018) Protracted dendritic growth in the typically developing human amygdala and increased spine density in young ASD brains. J Comp Neurol 526:262-274
Edmiston, Elizabeth; Jones, Karen L; Vu, Tam et al. (2018) Identification of the antigenic epitopes of maternal autoantibodies in autism spectrum disorders. Brain Behav Immun 69:399-407
Gangi, Devon N; Schwichtenberg, A J; Iosif, Ana-Maria et al. (2018) Gaze to faces across interactive contexts in infants at heightened risk for autism. Autism 22:763-768
Shen, Mark D; Nordahl, Christine W; Li, Deana D et al. (2018) Extra-axial cerebrospinal fluid in high-risk and normal-risk children with autism aged 2-4 years: a case-control study. Lancet Psychiatry 5:895-904
Pyles, Benjamin; Bailus, Barbara J; O'Geen, Henriette et al. (2018) Purified Protein Delivery to Activate an Epigenetically Silenced Allele in Mouse Brain. Methods Mol Biol 1767:227-239
CastaƱeda, Alejandro R; Pinkerton, Kent E; Bein, Keith J et al. (2018) Ambient particulate matter activates the aryl hydrocarbon receptor in dendritic cells and enhances Th17 polarization. Toxicol Lett 292:85-96
Napoli, Eleonora; Schneider, Andrea; Wang, Jun Yi et al. (2018) Allopregnanolone Treatment Improves Plasma Metabolomic Profile Associated with GABA Metabolism in Fragile X-Associated Tremor/Ataxia Syndrome: a Pilot Study. Mol Neurobiol :

Showing the most recent 10 out of 175 publications